Literature DB >> 3385640

Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability.

K D Meisheri1, L A Cipkus, C J Taylor.   

Abstract

The mechanism of smooth muscle relaxing effect of minoxidil sulfate (MxSO4) was investigated in isolated rabbit superior mesenteric artery. MxSO4 (5 X 10(-6) M) was found to effectively relax maximal norepinephrine (NE; at 5 X 10(-6) M) contraction, but failed to relax 80 mM K+-induced contraction. MxSO4-induced relaxation was endothelium independent. When the tissues were exposed to increased extracellular K+ (10-25 mM), and then contracted with NE, the relaxation response to MxSO4 was significantly attenuated. Tetraethylammonium (5-10 mM) pretreatment caused pronounced inhibition of MxSO4-induced relaxation. Pretreatment with ouabain (0.5-5 microM) also significantly inhibited MxSO4 relaxation. This effect of ouabain was found to be due to its effect on K+ gradient. These data suggested a role of K+ permeability during MxSO4 relaxation which was further confirmed when it was found that MxSO4 can cause a significant stimulation of 42K efflux from the mesenteric artery preloaded with 42K. It is suggested that MxSO4 may act as a K+ channel agonist to affect the plasmalemmal Ca++ permeability during agonist activation. Consistent with this, MxSO4 was demonstrated to cause an inhibition of NE-stimulated 45Ca influx in this tissue. Such a strong dependence on K+ permeability makes MxSO4 a unique vasodilator among the clinically used vasodilators.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385640

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulphate in rat isolated aorta.

Authors:  K Bray; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.

Authors:  K Bray; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

Review 3.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion.

Authors:  H Schmid-Antomarchi; S Amoroso; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 5.  Smooth muscle K+ channel openers; their pharmacology and clinical potential.

Authors:  A H Weston
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

6.  The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers.

Authors:  D J Webb; N Benjamin; P Vallance
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

7.  BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle.

Authors:  M C Sanguinetti; A L Scott; G J Zingaro; P K Siegl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Cyclic GMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery.

Authors:  D M Eckman; J S Weinert; I L Buxton; K D Keef
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Mechanism of activation of K+ channels by minoxidil-sulfate in Madin-Darby canine kidney cells.

Authors:  A Schwab; J Geibel; W Wang; H Oberleithner; G Giebisch
Journal:  J Membr Biol       Date:  1993-03       Impact factor: 1.843

Review 10.  KATP channels and cardiovascular disease: suddenly a syndrome.

Authors:  Colin G Nichols; Gautam K Singh; Dorothy K Grange
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.